Sistema de Salut de Catalunya
Institut Català de la Salut
[Cenit-García J] Virgen de las Nieves University Hospital, Granada, Spain. ibs.GRANADA—Biosanitary Research Institute, Granada, Spain. [Buendia-Gilabert C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Contreras-Molina C] Virgen de las Nieves University Hospital, Granada, Spain. [Puente-Fernández D] ibs.GRANADA—Biosanitary Research Institute, Granada, Spain. Department of Nursing, Faculty of Health Sciences, University of Granada, Granada, Spain. [Fernández-Castillo R] Department of Nursing, Faculty of Health Sciences, University of Granada, Granada, Spain. [García-Caro MP] ibs.GRANADA—Biosanitary Research Institute, Granada, Spain. Department of Nursing, Faculty of Health Sciences, University of Granada, Granada, Spain. CIMCYC—Mind, Brain and Behavior Research Center, University of Granada, Granada, Spain
Vall d'Hebron Barcelona Hospital Campus
2024-03-14T10:01:17Z
2024-03-14T10:01:17Z
2024-02-06
Neoplàsia de mama; Supervivents de càncer; Estigma social
Neoplasia de mama; Supervivientes de cáncer; Estigma social
Breast neoplasm; Cancer survivors; Social stigma
Background: The increase in breast cancer cases and breast cancer survival makes it advisable to quantify the impact of the health-related stigma of this disease. Purpose/Objectives: To develop and validate a breast cancer stigma scale in Spanish. Methods: Women diagnosed with, or survivors of, breast cancer were included. The development of the Breast Cancer Stigma Assessment Scale (BCSAS) involved both a literature review and personal interviews. Content validity was assessed using a Delphi study and a pilot test; construct validity was evaluated using an exploratory factor analysis; and convergent validity was assessed using six scales. Cronbach’s α internal consistency and test-retest reliability were used to determine the reliability of the scales. Results: 231 women responded to the 28-item scale. The BCSAS showed good reliability, with α = 0.897. Seven factors emerged: concealment (α = 0.765), disturbance (α = 0.772), internalized stigma (α = 0.750), aesthetics (α = 0.779), course (α = 0.599), danger (α = 0.502), and origin (α = 0.350). The test-retest reliability was 0.830 (p < 0.001). Significant correlation was observed with event centrality (r = 0.701), anxiety–depression (r = 0.668), shame (r = 0.645), guilt (r = 0.524), and quality of life (r = −0.545). Conclusions: The BCSAS is a reliable and valid measure of stigma in women with breast cancer and its survivors. It could be useful for detecting stigma risk and establishing psychotherapeutic and care priorities.
Article
Published version
English
Mama - Càncer; Psicometria; Estigma (Psicologia social); DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms; PSYCHIATRY AND PSYCHOLOGY::Behavioral Disciplines and Activities::Psychological Tests::Psychometrics; NAMED GROUPS::Persons::Survivors::Cancer Survivors; PSYCHIATRY AND PSYCHOLOGY::Behavior and Behavior Mechanisms::Behavior::Social Behavior::Social Stigma; ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama; PSIQUIATRÍA Y PSICOLOGÍA::disciplinas y actividades conductuales::pruebas psicológicas::psicometría; DENOMINACIONES DE GRUPOS::personas::sobrevivientes::supervivientes de cáncer; PSIQUIATRÍA Y PSICOLOGÍA::conducta y mecanismos de la conducta::conducta::conducta social::estigma social
MDPI
Healthcare;12(4)
https://doi.org/10.3390/healthcare12040420
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - HVH [3440]
